TCL Archive Iressa Just As Effective As Chemotherapy For Second-Line Therapy, Study Finds November 28, 2008
TCL Archive An old drug’s 21st century makeover begins with 84-fold price increase. Price hike of procarbazine astonishes brain tumor specialists. May 13, 2005
TCL Archive In Brief: Georgetown Professor Heads Cancer Therapy Evaluation Program; NCI-VA Branch Abolished September 7, 1979
TCL Archive In Brief: SBA Writing Guidelines to Implement Act Giving 1.25 Percent Of R&D Budget To Small Business July 23, 1982
TCL Archive In Brief: NCI To Supply Maytansine For Several Phase I Studies; Holleb Urges Referrals To “Experts” March 26, 1976
